Aggregator

California Democrat voters, for over twenty years, have inflicted unimaginable damage on the once great Golden State.

Luke Weaver was a pleasant dream for his latest team and a nightmare for his old one Saturday night.

Ben Bernanke’s Fed pulled off a miracle during the financial crisis of 2008 and 2009. What might Kevin Warsh be forced to pull out of his hat as the central bank’s new boss?

By all accounts, Justin Rose shouldn’t even have been playing in Saturday’s third round of the PGA Championship at Aronimink.

Alex Smalley has gotten himself into a bit of a quandary this week at the PGA Championship. And it’s all of his own doing.

Nicholas Kristof’s New York Times column marks a turning point in the American left’s divorce from Israel. The column, and the paper’s bombastic defense, ends any hope the marriage can be saved.

President Donald Trump may be preparing to toss a political grenade into Los Angeles’ mayoral race, by backing reality TV firebrand Spencer Pratt.

President Donald Trump is raring for a fight.

America's Medicine Supply Chain Is A National Security Vulnerability

Authored by Will Coggin via RealClearDefense,

The Chinese government is tightening the screws on American investment in its artificial intelligence sector. The core purpose is to keep U.S. capital out of technologies it deems “strategically sensitive” to national security. The protective action is a reminder that Washington also needs to prioritize insulating our own critical sectors from foreign adversaries.

Few industries are more important to our national security than healthcare. More than 131 million people - nearly two-thirds of all U.S. adults - use prescription medications. Yet the United States has allowed its pharmaceutical supply chains to become dangerously dependent on foreign rivals - particularly China. 

That vulnerability became strikingly clear during the pandemic, when U.S. leaders scrambled to secure masks, gloves, and other protective equipment from overseas. But our overreliance on China runs far deeper than just rubber and fabric. 

Today, China produces an outsized portion of the world’s Active Pharmaceutical Ingredients (APIs). These are the chemical backbone of most medicines, from insulin to antibiotics to asthma treatments. In a crisis—whether military confrontation, sanctions escalation, or a broader trade disagreement—Beijing would have us by the pills. 

It’s not theoretical. China has already demonstrated its willingness to weaponize supply chains. During recent trade disputes, Beijing leveraged its control over rare earth minerals—critical inputs for everything from aerospace systems to consumer electronics—to strengthen its negotiating position against the United States.

This kind of market dominance is by design. Every five years, leaders from across China congregate to decide a new national development plan. Because of the country’s highly-centralized structure, the government systematically targets strategic industries. 

In 2020, that five-year plan focused on electric vehicles and semiconductors. Now, Beijing is expanding its ambitions into biotechnology and “frontier science.” China is positioning itself not just as a pharmaceutical inputs supplier, but as a potential gatekeeper of future medical breakthroughs. 

Washington cannot let that happen. Fortunately, the U.S. has a powerful tool that our chief competitor across the Pacific doesn’t. Free market capitalism—as opposed to a top down, state-directed economy—is America’s competitive edge against China. Congress just needs to provide the right incentives so we can maximize on that advantage. 

Recent tax reforms that allow manufacturers to immediately expense some of the costs associated with research and development are a strong start. These legislative changes are providing businesses with greater certainty to invest in domestic production and expand “Made in America” pharmaceutical capacity.

President Trump is adding fuel to that momentum through his pro-business agenda. A 2025 order that streamlines approvals for companies looking to onshore drug production is a prime example. But executive action is fragile. America’s next leader could reverse that progress with the stroke of a pen. As the Trump administration continues to hack away at layers of red tape, lawmakers should codify these reforms.

America already has a strong foundation to build from. Indiana, North Carolina, and the U.S. territory of Puerto Rico, among other areas, anchor a significant share of existing American pharmaceutical production. By encouraging more innovation in our own backyard, these hubs can be strengthened to secure supply chains and reduce our dependence on China. 

Recent investments—including $300 million committed to Puerto Rico to expand domestic drug manufacturing capacity—are proof of concept. 

U.S. Congressman Nathaniel Moran (R-TX) recently said it best when he warned “America’s medicine cabinet runs through Beijing.” As China tightens its grip, securing America’s healthcare supply chains against foreign disruption is not just sound economic policy—it is a national security imperative.

Will Coggin is the managing director of the American Security Institute.

Tyler Durden Sat, 05/16/2026 - 22:10

Paging Luis Castillo.

California’s tech oligarchs are portraying themselves as victims, as the left clamors to tax their wealth away. Perhaps they should take some responsibility. Once widely admired as feisty disrupters, these super-rich moguls now define the establishment in California, a state with more billionaires than any other. California’s tech oligarchs are portraying themselves as victims, as...

Talk about a lounge lizard.

Buckle up. Sunday’s PGA Championship final round at Aronimink is guaranteed to be a wild ride. Seat belts required.

"After telling her to 'kill the baby,' and when she refused, he turned his anger on her, threatening her numerous times. He even went so far to choke her at our house."

The WHO Drums Up Fear With Ebola After Hantavirus Scare Fails

One of the biggest mistakes globalists made in their bid for perpetual medical authoritarianism during the Covid pandemic was reveling a bit too much.  Numerous high level officials from the WEF, WHO, the Imperial College of London and an army of politicians were giddy with excitement and bragged publicly about all the power they were going to grab as the masses huddled in fear of a virus with a 99.8% average survival rate.

This arrogance cost them, triggering an awakening of millions of former skeptics who are now avid "conspiracy theorists".  Today, the ability of the elitist class to sucker the populace into a new pandemic theater is greatly reduced.

No one believes them anymore.  And even if there was a legitimate biological threat, no one is going to trust an corrupt organization like the WHO to solve the problem.  

We have see the consequences of the covid farce with the recent Hantavirus scare, which has failed to inspire any noticeable reaction from the public.  As we noted a few days ago, the WHO has been exposed as a perpetrator of pandemic disinformation and is no longer trusted by the public. 

🇺🇳 | AHORA - El Tedros de la OMS dice que "espera más casos" de Hantavirus que se anuncien, debido a la brecha entre el primer caso y el momento en que se identificó el virus, ya que los pasajeros estaban interactuando en el barco durante este tiempo. pic.twitter.com/uVxOlMHkL4

— Alerta News 24 (@AlertaNews24) May 12, 2026

The US under the Trump Administration has exited the organization on these grounds, and as a result the WHO has lost at least 20% of its total funding.  It is now facing dire financial conditions.  In response, the UN and the establishment media have been running a spin campaign to present the WHO as indispensable.

Viruses do not respect borders.

I thank Prime Minister @sanchezcastejon not only for meeting #Spain’s legal duty under international law, but also for exercising his moral duty to show solidarity with, and compassion and kindness for, the passengers on MV Hondius cruise ship.… pic.twitter.com/yq3lM2yv88

— Tedros Adhanom Ghebreyesus (@DrTedros) May 12, 2026

For Hantavirus, the spread from human to human is rare and only occurs with the South American (or Andes) strain.  Contraction is difficult, with the virus passing from one person to another through "prolonged contact" often involving bodily fluids". 

The hysteria over Hantavirus has not materialized and the story is quickly fizzling out.  In response the WHO and Director-General Tedros Adhanom Ghebreyesus are taking to the media again to announce a new "Ebola threat" in the Democratic Republic of Congo.

Tedros is calling for "global solidarity" (and more funding) in response to the outbreak which has allegedly infected 13 people so far.  It should be noted that the DRC has had at least 17 Ebola outbreaks since the 1970s and none of them have led to a global pandemic threat.  The rhetoric of "global unity" is familiar, with much of the same language used during the covid pandemic.  

The last time the US had a "close call" with Ebola was in 2014 when the CDC identified over a dozen carriers in the US, and two deaths.  The end result?  Nothing happened, despite a media firestorm asserting that a deadly plague was just around the corner.

This is not to say that dangerous outbreaks are never going to happen, but it is rather convenient that the WHO is losing substantial funding and sway in geopolitics, and suddenly, common outbreaks are being treated like looming disasters in the media.  

Tyler Durden Sat, 05/16/2026 - 21:35

The controversy-filled meet drew roughly 2,000 spectators, many of whom voiced outrage over Hernandez competing in the girls division.

There’s a new leader of the Giants’ college scouting department.

Norway’s Kristoffer Reitan, the winner of last week’s Truist Championship, changed putters mid-tournament at the PGA Championship.

Animal rights activists could soon get their way if officials in San Francisco decide to vote to ban pet stores, following the cities like West Hollywood to do similar.

When it comes to UCLA softball’s pitching depth, it’s Taylor Tinsley and worry immensely. The Bruins ace has started every postseason game and pitched more than half her team’s innings over the season. UCLA pitcher Taylor Tinsley delivered Saturday against South Carolina. So it was no surprise that less than 24 hours after she walked...